Identification |
Name: | 2-[{[2,6-dideoxy-4-O-(2,6-dideoxy-3-C-methylhexopyranosyl)-3-C-methylhexopyranosyl]oxy}(methoxy)methyl]-10,12-dihydroxy-7,13a-dimethoxy-5-methyl-11-oxo-3a,8,9,10,11,13a-hexahydro-4H-spiro[2,4-epoxyfuro[3,2-b]naphtho[2,3-h]chromene-1,2'-oxiran]-8-yl 4-O-ac |
Synonyms: | LL-D49194alpha1;LL-D 49194 alpha1;2-[{[2,6-dideoxy-4-o-(2,6-dideoxy-3-c-methylhexopyranosyl)-3-c-methylhexopyranosyl]oxy}(methoxy)methyl]-10,12-dihydroxy-7,13a-dimethoxy-5-methyl-11-oxo-3a,8,9,10,11,13a-hexahydro-4h-spiro[2,4-epoxyfuro[3,2-b]naphtho[2,3-h]chromene-1,2'-oxiran]-8-yl 4-o-acetyl-2,6-dideoxy-3-c-methylhexopyranoside;Trioxacarcin A, 13-O-de(4-C-acetyl-2,6-dideoxy-alpha-L-xylo-hexopyranosyl)-16-O-demethyl-16-O-(2,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-xylo-hexopyranosyl)-3-C-methyl-alpha-L-xylo-hexopyranosyl)-13-O-methyl-;AC1L2RYG;AC1Q60MG;LL-D49194 ALPHA 1;AR-1D6381;NSC381856;NSC-381856;NCI60_003622;LS-157633;LL-D49194 ALPHA 1 (LEDERLE ANTIBIOTIC);Trioxacarcin A,6-dideoxy-.alpha.-L-xylo-hexopyranosyl)-16-O-demethyl-16-O-[2,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-.alpha.-L-xylo-hexopyranosyl)-3-C-methyl-.alpha.-L-xylo-hexopyranosyl]-13-O-methyl- |
CAS: | 99755-38-1 |
Molecular Formula: | C48H64O22 |
Molecular Weight: | 993.0086 |
InChI: | InChI=1/C48H64O22/c1-18-12-23-30(34(52)32-31(35(23)57-9)25(13-24(50)33(32)51)65-26-15-44(7,55)39(20(3)62-26)64-22(5)49)36-29(18)37-41-47(59-11,68-36)46(17-60-46)48(69-37,70-41)42(58-10)67-28-16-45(8,56)40(21(4)63-28)66-27-14-43(6,54)38(53)19(2)61-27/h12,19-21,24-28,37-42,50,52-56H,13-17H2,1-11H3 |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.51g/cm3 |
Refractive index: | 1.645 |
Flash Point: | °C |
Safety Data |
|
|